-
J.P. Morgan Overweight On Amgen Following Earnings (AMGN)
Thursday, April 21, 2011 - 10:16am | 205J.P. Morgan Chase & Co. has an Overweight rating and a $65 price target on shares of Amgen (NASDAQ: AMGN) following earnings. In a note to investors, J.P. Morgan writes, "Amgen's 1Q11 adjusted EPS of $1.34 beat JPM and Street estimates (JPMe: $1.30; cons: $1.29) on slightly higher revenues and...
-
UPDATE: Citi Raising Price Target On Gilead Sciences Inc (GILD)
Thursday, April 21, 2011 - 10:05am | 141Citi Investment Research is raising its price target on shares of Gilead Sciences Inc (NASDAQ: GILD) to $44 from $43 following earnings. It has a Hold rating on shares. In a note to investors, Citi writes, "While the stock is cheap and generates tremendous cash flow, the future stock performance...
-
Cephalon Recommends Shareholders Reject Valeant's Consent Solicitation to Remove Cephalon's Board of Directors
Thursday, April 21, 2011 - 9:51am | 86Cephalon, Inc. (NASDAQ: CEPH) today announced that it has filed a definitive Consent Revocation Statement with the Securities and Exchange Commission urging shareholders to reject Valeant Pharmaceuticals International Inc.'s (NYSE: VRX) proposals to remove Cephalon's entire Board of Directors and...
-
Morning Market Movers (TRAD, TZOO, DTLK, BIIB)
Thursday, April 21, 2011 - 9:46am | 111TradeStation Group Inc (NASDAQ: TRAD) shares surged 30.77% to $9.69 at 9:45 am. Monex Group announced its plans to acquire TRAD for around $411 million. Travelzoo Inc (NASDAQ: TZOO) jumped 22.51% to $90.50. TZOO reported a 30% year-over-year surge in its Q1 revenue. Datalink Corporation (NASDAQ:...
-
Pre-market News and Views
Thursday, April 21, 2011 - 9:40am | 505The holiday rally continues again this morning after strong corporate earnings reports by Apple Inc.(NASDAQ: AAPL), and Qualcomm Inc.(NASDAQ: QCOM). The S&P 500 Index e-mini futures(ES-M1) are trading higher by 5.00 points to 1333.00 per contract. Often, before a long holiday weekend the major...
-
Luna Names My Chung to Serve as CEO and President
Thursday, April 21, 2011 - 9:15am | 55Luna Innovations Incorporated (NASDAQ: LUNA) announced today that its Board of Directors has named My E. Chung to serve as the company's chief executive officer and president, effective as of April 25, 2011. On April 19, 2011, the Board also appointed Mr. Chung as a member of the Board, effective...
-
Jefferies Reports Encouraging Beat On Amgen
Thursday, April 21, 2011 - 9:14am | 116According to Jefferies, Amgen (NASDAQ: AMGN) saw a slight 1Q EPS beat. Jefferies said that Slight beat on 1Q top- and bottom-line but mix of good and bad (encouraging XGEVA sales, but disappointing Epogen sales; higher OpEx, but lower tax rate benefit). “AMGN maintains FY11 guidance and to detail...
-
Amgen Guides FY2015 Revenues $16-$18B; Adj. EPS of $7.25-$8.60; Authorized to Repurchase $5B in Amgen Shares (AMGN)
Thursday, April 21, 2011 - 9:04am | 27Amgen (NASDAQ: AMGN) Guides FY2015 Revenues $16-$18B; Adj. EPS of $7.25-$8.60; Authorized to Repurchase $5B in Amgen Shares.
-
Biotech/Pharma Investor Spotlight; Profile for BioSante Pharmaceuticals (NASDAQ: BPAX) and its Lead Products, LibiGel and Bio-T-Gel
Thursday, April 21, 2011 - 9:00am | 36Point Roberts, WA - April 21, 2011 (Investorideas.com Newswire) Investorideas.com, a leader in sector stock research including biotech and pharma stocks, profiles BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and its lead products, LibiGel (testosterone gel) and Bio-T-Gel.
-
Biotech/Pharma Investor Spotlight; Profile for BioSante Pharmaceuticals (NASDAQ: BPAX) and its Lead Products, LibiGel and Bio-T-Gel
Thursday, April 21, 2011 - 9:00am | 36Point Roberts, WA - April 21, 2011 (Investorideas.com Newswire) Investorideas.com, a leader in sector stock research including biotech and pharma stocks, profiles BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and its lead products, LibiGel (testosterone gel) and Bio-T-Gel.
-
Threshold Announces Unexpected Death of Its Chief Medical Officer (THLD)
Thursday, April 21, 2011 - 8:34am | 116Threshold Pharmaceuticals, Inc. (Nasdaq: THLD), today announced the death of John G. Curd, M.D., president and chief medical officer. Dr. Curd died suddenly and unexpectedly of apparent natural causes on April 20. "We are very much in shock and grief by this sudden loss of our colleague and...
-
UPDATE: Jefferies Raises PT on Cepheid to $35 (CPHD)
Thursday, April 21, 2011 - 8:33am | 82Jefferies is out with its report today on Cepheid (NASDAQ: CPHD), raising its PT from $30 to $35. In a note to clients, Jefferies writes, "CPHD's 1Q11 GAAP EPS of $0.01 was $0.02 ahead of consensus on better than expected revenue growth and profit trends. We are raising our 2011 and 2012 EPS...
-
UPDATE: Amgen CEO Says Will Institute Dividend of 20% of Net Income This Year (AMGN)
Thursday, April 21, 2011 - 8:33am | 23UPDATE: Amgen CEO Says Will Institute Dividend of 20% of Net Income This Year (NASDAQ: AMGN)
-
Amgen Says Will Institute Dividend This Year (AMGN)
Thursday, April 21, 2011 - 8:32am | 17Amgen Says Will Institute Dividend This Year (NASDAQ: AMGN)
-
Biogen Idec Skyrocketing 20% On Drug Trial (BIIB)
Thursday, April 21, 2011 - 8:23am | 201Shares of Biogen Idec Inc. (NASDAQ: BIIB) are skyrocketing in pre-market, gaining more than 20% after the company reported earnings, and reported favorable results from its BG-12 MS Pill Trial. “We had a very solid first quarter based on the performance of our three blockbuster products,” said...